- Home
- ACOG vs ICAD Comparison
ACOG vs ICAD Comparison
Compare ACOG & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACOG
- ICAD
- Stock Information
- Founded
- ACOG 2000
- ICAD 1984
- Country
- ACOG Canada
- ICAD United States
- Employees
- ACOG N/A
- ICAD N/A
- Industry
- ACOG
- ICAD Medical/Dental Instruments
- Sector
- ACOG
- ICAD Health Care
- Exchange
- ACOG Nasdaq
- ICAD Nasdaq
- Market Cap
- ACOG 80.3M
- ICAD 93.9M
- IPO Year
- ACOG N/A
- ICAD 1986
- Fundamental
- Price
- ACOG $7.43
- ICAD $3.60
- Analyst Decision
- ACOG Strong Buy
- ICAD Hold
- Analyst Count
- ACOG 1
- ICAD 1
- Target Price
- ACOG $20.00
- ICAD N/A
- AVG Volume (30 Days)
- ACOG 80.6K
- ICAD 1.8M
- Earning Date
- ACOG 05-15-2025
- ICAD 05-19-2025
- Dividend Yield
- ACOG N/A
- ICAD N/A
- EPS Growth
- ACOG N/A
- ICAD N/A
- EPS
- ACOG N/A
- ICAD N/A
- Revenue
- ACOG N/A
- ICAD $19,608,000.00
- Revenue This Year
- ACOG N/A
- ICAD $2.58
- Revenue Next Year
- ACOG N/A
- ICAD $14.78
- P/E Ratio
- ACOG N/A
- ICAD N/A
- Revenue Growth
- ACOG N/A
- ICAD 13.22
- 52 Week Low
- ACOG $3.75
- ICAD $1.18
- 52 Week High
- ACOG $7.00
- ICAD $3.78
- Technical
- Relative Strength Index (RSI)
- ACOG N/A
- ICAD 72.92
- Support Level
- ACOG N/A
- ICAD $3.42
- Resistance Level
- ACOG N/A
- ICAD $3.58
- Average True Range (ATR)
- ACOG 0.00
- ICAD 0.13
- MACD
- ACOG 0.00
- ICAD 0.03
- Stochastic Oscillator
- ACOG 0.00
- ICAD 78.08
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment includes image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.